Latest from Brian Monroe

Coronavirus herd immunity is within reach, but what happens if we fall short?

Johns Hopkins University Epidemiologist Gypsyamber D'Souza explains how the U.S. can reach coronavirus herd immunity and what happens if that goal is missed.
  • Jun 9, 2021

How QAnon found a home in Britain | Hannah Explains

Fueled by anti-lockdown protests and child abuse conspiracies, QAnon has taken a new direction in Britain over the course of the pandemic.
  • May 28, 2021

Hanger is real

Neuroscience shows AgRP “hangry” neurons produce negative feelings along with hunger, as double motivation to find food.
  • May 27, 2021

Comedians remember the 'no sugar' comedy of the late Paul Mooney

Director Robert Townsend and other celebrities reflect on the comedy legend Paul Mooney's raw humor.
  • May 21, 2021

How Biden's nominees could shape the Postal Service's, and Louis DeJoy's, future

The USPS is facing financial, service and public relations crises, but the president's new appointees could have an impact beyond restoring timely service.
  • May 6, 2021

17 requests for backup in 78 minutes

A reconstruction shows how failures of planning and preparation left police at the Capitol severely disadvantaged on Jan. 6.
  • Apr 15, 2021

Understanding the coronavirus variants

As new variants of coronavirus continue to be discovered, here's what you need to know about how these mutations work and how they spread.
  • Apr 8, 2021

Perspective | Transgender people in Britain explain why transphobia is on the rise in the U.K.

The Post’s Hannah Jewell spoke to British trans people about how the media and government have fueled rising transphobia.
  • Mar 31, 2021

Americans started wearing face masks a year ago. Where do we go from here?

The rapid spread of covid-19 in the United States began in early 2020. A lot has changed in our day-to-day lives since then, including the use of face masks.
  • Mar 8, 2021

How Novavax uses moth cells to create its coronavirus vaccine

Novavax, a biotech company in Gaithersburg, Md., uses recombinant protein technology to create its coronavirus vaccine.
  • Mar 3, 2021